Bicocca Open Archive

Logo unimib boa
CIARDULLO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.601
NA - Nord America 5.283
EU - Europa 3.369
SA - Sud America 986
AF - Africa 182
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.104
SG - Singapore 2.080
CN - Cina 1.095
IT - Italia 891
HK - Hong Kong 752
BR - Brasile 731
VN - Vietnam 703
RU - Federazione Russa 616
DE - Germania 459
SE - Svezia 306
IE - Irlanda 267
GB - Regno Unito 191
IN - India 186
FR - Francia 159
KR - Corea 125
CA - Canada 109
AR - Argentina 105
ID - Indonesia 105
BD - Bangladesh 89
NL - Olanda 80
FI - Finlandia 77
IQ - Iraq 76
ZA - Sudafrica 54
TR - Turchia 53
JP - Giappone 51
PK - Pakistan 49
CH - Svizzera 48
UA - Ucraina 47
MX - Messico 45
ES - Italia 44
PL - Polonia 42
SA - Arabia Saudita 42
EC - Ecuador 38
PH - Filippine 34
AU - Australia 33
CO - Colombia 33
AT - Austria 31
EG - Egitto 31
VE - Venezuela 23
UZ - Uzbekistan 22
BE - Belgio 21
MA - Marocco 18
DK - Danimarca 16
JO - Giordania 16
IR - Iran 14
PY - Paraguay 14
CL - Cile 13
DZ - Algeria 13
MY - Malesia 13
TW - Taiwan 13
AE - Emirati Arabi Uniti 12
RO - Romania 12
KE - Kenya 11
OM - Oman 11
PE - Perù 10
PT - Portogallo 10
UY - Uruguay 10
NP - Nepal 9
TH - Thailandia 9
BG - Bulgaria 8
BO - Bolivia 8
ET - Etiopia 8
LT - Lituania 8
NG - Nigeria 8
PA - Panama 8
CZ - Repubblica Ceca 7
TN - Tunisia 7
AZ - Azerbaigian 6
IL - Israele 6
KZ - Kazakistan 6
SN - Senegal 6
DO - Repubblica Dominicana 5
AL - Albania 4
BY - Bielorussia 4
GR - Grecia 4
LB - Libano 4
PS - Palestinian Territory 4
ZM - Zambia 4
AO - Angola 3
BW - Botswana 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NO - Norvegia 3
ZW - Zimbabwe 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CY - Cipro 2
GD - Grenada 2
HU - Ungheria 2
JM - Giamaica 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SC - Seychelles 2
SO - Somalia 2
BN - Brunei Darussalam 1
CG - Congo 1
Totale 15.437
Salva come PNG Salva come JPEG
Città #
Singapore 1.200
Hong Kong 726
Ann Arbor 702
Ashburn 491
San Jose 412
Santa Clara 301
Frankfurt am Main 286
Dublin 256
Chicago 242
Hefei 238
Milan 232
Ho Chi Minh City 206
Chandler 201
Beijing 200
New York 197
Fairfield 175
Hanoi 152
Los Angeles 149
Dallas 139
Seoul 105
The Dalles 102
Wilmington 102
Princeton 96
Lauterbourg 86
Seattle 78
Jakarta 71
Woodbridge 70
Houston 68
Cambridge 67
London 64
São Paulo 62
Altamura 58
Moscow 57
Munich 53
Shanghai 52
Helsinki 48
Lawrence 47
Rome 47
Buffalo 45
Zurich 44
Council Bluffs 39
San Diego 36
Da Nang 32
Baghdad 30
Haiphong 30
Montreal 30
Boardman 29
Tokyo 27
Bari 26
Warsaw 26
Dong Ket 24
Nuremberg 24
Orem 24
Toronto 24
Guangzhou 23
Monza 22
Rio de Janeiro 22
Biên Hòa 20
Nanjing 20
Riyadh 20
Tashkent 20
Kent 19
Atlanta 18
Hải Dương 18
Johannesburg 18
Lappeenranta 18
Mumbai 18
Quito 18
Brooklyn 17
Brussels 17
Dhaka 17
Stockholm 17
Phoenix 16
Kocaeli 15
Porto Alegre 15
Pune 15
Vienna 15
Amman 14
Amsterdam 14
Brasília 14
Chennai 14
Belo Horizonte 13
Boston 13
Cairo 13
Cape Town 13
Istanbul 13
Melbourne 13
Mexico City 13
New Delhi 13
Salvador 13
Sydney 13
Curitiba 12
Erbil 12
Hyderabad 12
Jeddah 12
Manchester 12
Salt Lake City 12
San Francisco 12
Carate Brianza 11
Changsha 11
Totale 9.038
Salva come PNG Salva come JPEG
Nome #
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction 591
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 448
Exploring the landscape of steatotic liver disease in the general US population 419
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study 384
Endocrinology and Metabolic Diseases (Including Diabetes) 314
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 270
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 247
Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting 220
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 219
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 211
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 211
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 202
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 201
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 198
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 190
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 189
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 188
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 188
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 187
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 186
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 184
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 181
Lack of awareness of liver organ damage in patients with type 2 diabetes 180
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 179
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 179
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 176
Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes 174
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 174
Authors' response to Guo, Wei et al. 170
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 170
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 169
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 168
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 168
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study) 167
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 164
Authors' reply to Zou et al 164
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 164
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 161
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 160
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting 159
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 157
An unexpected bilateral mass after total thyroidectomy 157
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 157
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 155
Evaluating the Prognostic Value of the Triglyceride–Glucose Index in Different Populations: A Critical Analysis 154
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 153
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus 149
Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study 148
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 146
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents 146
Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition 145
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 145
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 145
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016 144
Medication Use Before and After Different Bariatric Surgery Procedures: Results from a Population-Based Cohort Study 142
Risk stratification tools for heart failure in the diabetes clinic 142
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 142
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 141
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes 139
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 137
Sex-related association of NAFLD and liver fibrosis with body fat distribution in the general US population 136
Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population 135
Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population 135
Serum neurofilament light chain levels are associated with all-cause mortality in the general US population 132
Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease 129
Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. women 128
Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study 127
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment 127
Authors' reply to Shang et al. 127
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 126
Liver stiffness is associated with all-cause mortality in patients with NAFLD: A systematic review and meta-analysis 125
Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis 125
Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study 125
Reply [to: Use of FibroScan–AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US...] 120
NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population 120
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence 116
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 116
Comment on “An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD” 115
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 115
Global multi-stakeholder endorsement of the MAFLD definition 115
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis 114
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes 110
Chronic Hepatitis B and MASLD: Growing Awareness and Unmet Clinical Needs 109
Non-invasive scores of liver fibrosis in morbidly obese patients 108
Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States 108
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 107
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner? 105
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes and association with micro- and macrovascular complications 105
Twenty-year trends in heart failure among U.S. adults, 1999–2018: The growing impact of obesity and diabetes 102
Control of Blood Glucose and Cardiovascular Risk Profile 102
Trends in prevalence of probable fibrotic nonalcoholic steatohepatitis in the United States, 1999-2016 97
Advances in fibrosis biomarkers in nonalcoholic fatty liver disease 96
Silent threats: how NAFLD and hypertension team up in young adults, and the role of sex 91
Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD 90
Prevalence of Noninvasively Detected Clinically Significant Portal Hypertension Among U.S. Adults With and Without Diabetes 89
Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes 88
Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD: A Cross-Sectional Study From the NHANES Database 51
Effect of Weight Loss on Clinical Outcomes in Patients With Chronic Gastrointestinal and Liver Diseases 37
Totale 15.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 144 88 134
2021/2022741 117 88 99 42 25 52 28 35 50 62 44 99
2022/20231.240 146 226 123 108 92 228 40 71 87 26 58 35
2023/20241.236 89 42 84 102 112 216 166 53 91 53 34 194
2024/20254.090 215 404 309 233 331 220 288 121 343 517 427 682
2025/20267.265 883 717 637 902 859 410 1.182 438 640 597 0 0
Totale 15.821